Closed
FAST-Trac Award
Funding for translational Angelman syndrome research
Last Update: April 27, 2026
Funding available
$ 150,000
Timeline
- Receipt of requests is now closed
Location
Canada
Overview
FAST-Trac Awards provide up to $150,000 per year for translational research in Angelman syndrome. The program supports therapeutic development, biomarkers, outcome measures, disease models, and clinical readiness activities.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop a new program or service
- Enhance an existing program
- Conduct research and development activities
Eligible Funding
- Maximum amount : 150,000 $
Timeline
- Receipt of requests is now closed
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- People with disabilities
- Nonprofits / charities
- Academia / students
Revenue structures
- 100% donations / grants
Scope
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Translational research on potential Angelman syndrome treatments.
- Development of gene-modifying, disease-modifying, or symptom-alleviating therapeutics.
- High-throughput drug screening and novel disease model development.
- Biomarker and outcome measure development for clinical readiness.
- Preparation of clinical sites and natural history data collection.
Documents Needed
- Letter of Intent
- Research plan
- Budget justification
- Biographical sketch
- Other support information
Eligibility
Who is eligible?
- Nonprofit institutions.
- Research teams working on Angelman syndrome.
- Qualified individuals with PhD- or MD-level training.
Who is not eligible
- For-profit institutions.
- Applicants without PhD- or MD-level training.
Eligible expenses
- Reagents and materials, including cell lines and animal model lines.
- Specialized services such as sequencing, proteomics, metabolomics, and manufacturing.
- Specialized equipment or software needed for the project.
- Personnel costs, including salaries and fringe benefits.
- Travel support for the annual FAST scientific symposium.
Ineligible Costs and Activities
- Indirect costs on tuition, equipment, software, or software licenses.
- Travel costs beyond the included symposium stipend, unless not used and returned.
Processing and Agreement
- Applications are reviewed through scientific peer review by FAST’s Scientific Advisory Board.
- Applications are scored for scientific merit, innovation, translational impact, alignment with FAST’s mission, design, rationale, budget, and feasibility.
- SAB feedback may require applicant responses before final review.
- Funding recommendations move to the Scientific Director Panel and then to FAST’s Board of Directors for final approval.
- FAST aims to provide a funding response within six weeks of submission.
Additional information
- Applicants should submit a Letter of Intent before applying.
- Applications are accepted on a rolling basis.
- Final funding requires approval by FAST’s Board of Directors.
- Projects with human or animal subjects require IRB or IACUC approval before funds are released.
Contacts
Frequently Asked Questions about the FAST-Trac Award Program
What is the FAST-Trac Award?
FAST-Trac Awards provide up to $150,000 per year for translational research in Angelman syndrome. The program supports therapeutic development, biomarkers, outcome measures, disease models, and clinical readiness activities.
How much funding can be received?
FAST-Trac Award Funds up to $150,000 of admissible expenses.
Who is eligible for the FAST-Trac Award program?
To be eligible for the FAST-Trac Award program, you must:
Nonprofit institutions only.
PhD- or MD-level applicants.
Full-time research commitment.
What expenses are eligible under FAST-Trac Award?
Translational research on potential Angelman syndrome treatments.
Development of gene-modifying, disease-modifying, or symptom-alleviating therapeutics.
High-throughput drug screening and novel disease model development.
Biomarker and outcome measure development for clinical readiness.
Preparation of clinical sites and natural history data collection.
Who can I contact for more information about the FAST-Trac Award?
You can contact Foundation for Angelman Syndrome Therapeutics (FAST) by email at grants@cureangelman.org or by phone at 630-852-3278.
Where is the FAST-Trac Award available?
The FAST-Trac Award program is available across Canada.
Who are the financial supporters of the FAST-Trac Award?
FAST-Trac Award is funded by Foundation for Angelman Syndrome Therapeutics (FAST)